Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
sharewise is moving On the weekend of 22/23 August the new sharewise becomes the main site. Have a look now and tell us what you miss. Go to the new sharewise What changes
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
sell

Intellia Therapeutics Inc sell The Goldman Sachs Group, Inc.

Intellia Therapeutics Inc
Start price
€11.14
28.04.26 / 50%
Target price
-
28.04.27
Performance (%)
-9.69%
Price
€10.06
19:10
Summary
This prediction is currently active. With a performance of -9.69%, the SELL prediction by The_Goldman_Sachs_Gr is trending in the right direction. This prediction currently runs until 28.04.27. The prediction end date can be changed by The_Goldman_Sachs_Gr at any time. The_Goldman_Sachs_Gr has 50% into this prediction
Performance without dividends (%)
Name 1w 1m
Intellia Therapeutics Inc 0.192% 0.192%
iShares Core DAX® -0.046% 5.960%
iShares Nasdaq 100 0.922% 3.693%
iShares Nikkei 225® 3.014% 6.638%
iShares S&P 500 -0.359% 2.747%

Comments by The_Goldman_Sachs_Gr for this prediction

In the thread Intellia Therapeutics Inc diskutieren

Intellia Therapeutics (NTLA) had its "sell" rating reaffirmed by The Goldman Sachs Group, Inc..
Ratings data for NTLA provided by MarketBeat

The Goldman Sachs Group, Inc. 
0
Report Share
28.04.26 Sell -9.69%

Stopped prediction by The_Goldman_Sachs_Gr for Intellia Therapeutics Inc

sell
Intellia Therapeutics Inc

Start price
Target price
Perf. (%)
€9.21
28.02.25
€8.65
28.02.26
19.35%
01.03.26

The Goldman Sachs Group, Inc. 
28.02.25 50%